Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HIV-1 pol inhibitors(Human immunodeficiency virus type 1 Pol protein inhibitors), RT inhibitors(Viral reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H13N5O4 |
InChIKeyHBOMLICNUCNMMY-XLPZGREQSA-N |
CAS Registry30516-87-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | - | - | |
HIV Infections | Phase 2 | - | - |
Not Applicable | - | 68 | (pqqmcqzdfh) = ptdjolbghu ixikgrmmhg (jwjpfvxura ) View more | - | 01 Jan 2018 | ||
(pqqmcqzdfh) = jtxcwwowxd ixikgrmmhg (jwjpfvxura ) View more | |||||||
Not Applicable | - | 140 | xyuphlaxqm(vqprteimcp) = njumqjxiqz inizovsfeg (fydoyswhhl ) View more | - | 01 Jan 2007 | ||
xyuphlaxqm(vqprteimcp) = atclaadnss inizovsfeg (fydoyswhhl ) View more | |||||||
Not Applicable | 4 | gwmojnragf(ccvolugdkv) = miwnxhkstp odcaortsow (gizkbrpwvo ) | - | 01 Jan 2003 | |||
Not Applicable | 36 | (mklfczkave) = hwdwwopjyw odnenaweyk (znhlckxcct ) | - | 01 Jan 2002 | |||
Not Applicable | 12 | yqqwcjqvsw(ffczqjkrix) = cfiwmsuxcr azkvqwdzer (kenvpzzpjq ) | - | 01 Jan 2001 |